Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer
- PMID: 29946375
- PMCID: PMC6006560
- DOI: 10.1186/s13148-018-0519-7
Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer
Abstract
Background: Cutaneous squamous cell carcinoma (cSCC) occurs 65-200 times more in immunosuppressed organ transplant patients than in the general population. T cells, which are targeted by the given immunosuppressive drugs, are involved in anti-tumor immune surveillance and are functionally regulated by DNA methylation. Prior to kidney transplantation, we aim to discover differentially methylated regions (DMRs) in T cells involved in de novo post-transplant cSCC development.
Methods: We matched 27 kidney transplant patients with a future de novo cSCC after transplantation to 27 kidney transplant patients without cSCC and studied genome-wide DNA methylation of T cells prior to transplantation. From 11 out of the 27 cSCC patients, the DNA methylation of T cells after transplantation was also examined to assess stability of the observed differences in DNA methylation. Raw methylation values obtained with the 450k array were confirmed with pyrosequencing.
Results: We found 16 DMRs between patients with a future cSCC and those who do not develop this complication after transplantation. The majority of the DMRs were located in regulatory genomic regions such as flanking bivalent transcription start sites and bivalent enhancer regions, and most of the DMRs contained CpG islands. Examples of genes annotated to the DMRs are ZNF577, coding for a zinc-finger protein, and FLOT1, coding for a protein involved in T cell migration. The longitudinal analysis revealed that DNA methylation of 9 DMRs changed significantly after transplantation. DNA methylation of 5 out of 16 DMRs was relatively stable, with a variation in beta-value lower than 0.05 for at least 50% of the CpG sites within that region.
Conclusions: This is the first study demonstrating that DNA methylation of T cells from patients with a future de novo post-transplant cSCC is different from patients without cSCC. These results were obtained before transplantation, a clinically relevant time point for cSCC risk assessment. Several DNA methylation profiles remained relatively stable after transplantation, concluding that these are minimally affected by the transplantation and possibly have a lasting effect on post-transplant cSCC development.
Keywords: Cutaneous squamous cell carcinoma; DNA methylation; Epigenetics; Non-melanoma skin cancer; Solid organ transplantation; T lymphocytes.
Conflict of interest statement
Anonymized biobank samples were used in this study; this approach had been approved by the local ethical committee (MEC-2015-642).Not applicableThe authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures




Similar articles
-
Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.Clin Exp Immunol. 2019 Sep;197(3):341-351. doi: 10.1111/cei.13309. Epub 2019 May 30. Clin Exp Immunol. 2019. PMID: 31059128 Free PMC article. Clinical Trial.
-
UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes.EBioMedicine. 2020 Jul;57:102835. doi: 10.1016/j.ebiom.2020.102835. Epub 2020 Jun 20. EBioMedicine. 2020. PMID: 32574963 Free PMC article.
-
Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma.EBioMedicine. 2021 May;67:103383. doi: 10.1016/j.ebiom.2021.103383. Epub 2021 May 14. EBioMedicine. 2021. PMID: 34000624 Free PMC article.
-
Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:33-37. doi: 10.1111/jdv.16025. J Eur Acad Dermatol Venereol. 2019. PMID: 31833604 Review.
-
Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.Dermatol Ther. 2021 May;34(3):e14907. doi: 10.1111/dth.14907. Epub 2021 Mar 2. Dermatol Ther. 2021. PMID: 33619803 Review.
Cited by
-
The roles of FLOT1 in human diseases (Review).Mol Med Rep. 2023 Nov;28(5):212. doi: 10.3892/mmr.2023.13099. Epub 2023 Sep 29. Mol Med Rep. 2023. PMID: 37772385 Free PMC article. Review.
-
Unveiling the Role of DNA Methylation in Kidney Transplantation: Novel Perspectives toward Biomarker Identification.Biomed Res Int. 2019 Jan 15;2019:1602539. doi: 10.1155/2019/1602539. eCollection 2019. Biomed Res Int. 2019. PMID: 30766879 Free PMC article. Review.
-
Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.Biomolecules. 2021 Dec 3;11(12):1826. doi: 10.3390/biom11121826. Biomolecules. 2021. PMID: 34944472 Free PMC article.
-
Exhaustion of CD8+ central memory responder T cell differentiation provokes non-melanoma skin cancer in elderly kidney transplant recipients.Front Immunol. 2023 May 23;14:1164284. doi: 10.3389/fimmu.2023.1164284. eCollection 2023. Front Immunol. 2023. PMID: 37287988 Free PMC article.
-
MethAgingDB: a comprehensive DNA methylation database for aging biology.Sci Data. 2025 Jul 14;12(1):1216. doi: 10.1038/s41597-025-05538-z. Sci Data. 2025. PMID: 40659676 Free PMC article.
References
-
- Krynitz B, Edgren G, Lindelof B, Baecklund E, Brattstrom C, Wilczek H, Smedby KE. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—a Swedish population-based study. Int J Cancer. 2013;132(6):1429–1438. doi: 10.1002/ijc.27765. - DOI - PubMed
-
- Euvrard S, Kanitakis J, Decullier E, Butnaru AC, Lefrançois N, Boissonnat P, Sebbag L, Garnier J-L, Pouteil-Noble C, Cahen R, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation. 2006;81(8):1093–1100. doi: 10.1097/01.tp.0000209921.60305.d9. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases